Efficacy and safety of date palm leaf-based ointment for treatment of cutaneous warts: A pilot clinical trial.


Journal

Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070

Informations de publication

Date de publication:
12 2022
Historique:
revised: 20 09 2022
received: 10 06 2022
accepted: 21 10 2022
pubmed: 9 11 2022
medline: 21 12 2022
entrez: 8 11 2022
Statut: ppublish

Résumé

Despite the considerably high prevalence of cutaneous warts, no optimally effective and safe treatment is available. Leaves of date palm (Phoenix dactylifera L.; Arecaceae) have long been used in Iran's folk medicine as a remedy for warts. To assess the state-of-the-art evidence on using P. dactylifera L. for warts, we conducted a systematic review using CINAHL (via EBSCO), Embase, Medline (via PubMed), ProQuest, Scopus, and Web of Science. We conducted an open-label uncontrolled pilot clinical study to evaluate the efficacy and safety of a proprietary topical date palm leaf-based ointment for the treatment of various types of nongenital warts. This study consisted of an 8-week treatment phase and a 4-week follow-up phase. The assessed outcomes included complete clearance, patient satisfaction (on Likert scale), and the occurrence of any adverse effect. The systematic review demonstrated that the effects of date palm on warts have not been scientifically studied. Thirty patients entered the study with a mean age of 29.5 years (SD = 14.04); among which 17 were female and 13 were male. The patients presented diverse types of warts: verruca vulgaris 15 (50%), plantar 9 (30%), plane 2 (7%), periungual 2 (7%), and warts at multiple sites 2 (7%). In this trial, 19 patients (63.3%) experienced complete clearance and 5 patients (16.6%) experienced partial clearance. Eight patients (26.67%) dropped out during the study. 21 (70%) patients were very satisfied (score on Likert scale = 5) while 1 (3.3%) patient with partial clearance was somewhat satisfied (score on Likert scale = 4). No adverse effect was observed. The results of this pilot study indicate that the date palm leaf-based ointment is a promising treatment whose efficacy and safety should be further investigated in a randomized controlled clinical trial.

Identifiants

pubmed: 36346021
doi: 10.1111/dth.15968
doi:

Substances chimiques

Ointments 0

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15968

Subventions

Organisme : Aras Pharmaceuticals Ltd.

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Littrè E. Oeuvres complètes d'Hippocrate. Baillière; 1861.
Loo SK, Tang WY. Warts (non-genital). BMJ Clin Evid. 2014;2014:1710.
Leigh IM, Glover MT. Skin cancer and warts in immunosuppressed renal transplant recipients. Recent Results Cancer Res. 1995;139:69-86.
Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696-712.
Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012;2012(9):Cd001781.
Campbell MA, Mpas P. Non-genital Warts: A review of current treatments.
Gruca M, Blach-Overgaard A, Balslev H. African palm ethno-medicine. J Ethnopharmacol. 2015;165:227-237.
Allahyari S, Pakbin B, Amani Z, et al. Antiviral activity of Phoenix dactylifera extracts against herpes simplex virus type 1: an animal study. Comp Clin Pathol. 2021;30(6):945-951.
Jassim SA, Naji MA. In vitro evaluation of the antiviral activity of an extract of date palm (Phoenix dactylifera L.) pits on a pseudomonas phage. Evid Based Complement Alternat Med. 2010;7(1):57-62.
Rathbone J, Carter M, Hoffmann T, Glasziou P. Better duplicate detection for systematic reviewers: evaluation of systematic review assistant-deduplication module. Syst Rev. 2015;4(1):6.
Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: systematic review. BMJ. 2002;325(7362):461.
Boulenouar N, Marouf A, Cheriti A. Antifungal activity and phytochemical screening of extracts from Phoenix dactylifera L. cultivars. Nat Prod Res. 2011;25(20):1999-2002.
Verma H, Dwivedi S. Properties of a virus inhibiting agent, isolated from plants which have been treated with leaf extracts from Bougainvillea spectabilis. Physiol Plant Pathol. 1984;25(1):93-101.
Chattopadhyay D, Naik TN. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Rev Med Chem. 2007;7(3):275-301.
Vilhelmova-Ilieva N, Galabov AS, Mileva M. Tannins as antiviral agents. Tannins-Structural Properties, Biological Properties and Current Knowledge. IntechOpen; 2019.
Theisen LL, Erdelmeier CA, Spoden GA, et al. Tannins from Hamamelis virginiana bark extract: characterization and improvement of the antiviral efficacy against influenza a virus and human papillomavirus. PLoS One. 2014;9(1):e88062.
Preregistration and proposal details of Evaluation of the efficacy and safety of ([WartOver]) topical ointment for the treatment of cutaneous warts: a randomized triple-blind clinical trial. 2022; https://ethics.research.ac.ir/EthicsProposalViewEn.php?id=280295.

Auteurs

Azin Ayatollahi (A)

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.

Nima Aramipour (N)

Aras Pharmaceuticals Ltd., Tehran, Iran.
Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Arash Sadri (A)

Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Lyceum Scientific Charity, Tehran, Iran.
Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Alireza Firooz (A)

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.

Reza M Robati (RM)

Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mahsa Fattahi (M)

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.

Masoud Ayazi (M)

Aras Pharmaceuticals Ltd., Tehran, Iran.

Mohammad Saber (M)

Aras Pharmaceuticals Ltd., Tehran, Iran.
Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH